The test will take place in Belagavi, Bengaluru, Kalaburagi, Mysuru and Shivamogga. Karnataka will conduct a COVID-19 vaccine trial in five districts, including Bengaluru across the state, on Saturday, an official said Friday. “A test for COVID-19 vaccination will be carried out in five districts: Belagavi, Bengaluru, Kalaburagi, Mysuru and …
Read More »As Delhi Prepares for Covid Shot to the Arm, Here’s How the Chain of Events Will Play Out | Delhi News
NEW DELHI: After arriving at Indira Gandhi International Airport by special cargo planes, the Covid-19 vaccine vials will be brought to the city’s two cold storage facilities in special refrigerated vans. From there, the vaccine will be transported to 609 cold chain points in special vans, some of which could …
Read More »Live Coronavirus: Vaccine Safety Top Concern, Health Minister Says As Nationwide Trial Begins
Union states and territories across the country are conducting a trial of the coronavirus vaccination process today. It is being carried out in 116 districts at 259 sites, the Health Ministry said on Saturday. The test will be carried out in an integral way of the COVID-19 vaccination process and …
Read More »Key meeting on COVID-19 vaccine approval today, day before Pan-India dry test
India hopes to have a vaccine approved in the new year. Highlight Panel of government experts to review submissions from drug manufacturers Final approval with the drug regulator after expert recommendation Tomorrow second mock vaccination campaign New Delhi: Applications for emergency use approval for coronavirus vaccines submitted by the Serum …
Read More »Coronavirus | COVID-19 Vaccine Near Approval, India’s General Drug Controller Hints
VG Somani, Comptroller General of Drugs of India (DCGI), in a webinar on Thursday indicated that India was close to approving a COVID-19 vaccine. Mr. Somani was participating in a webinar, organized by the Department of Biotechnology, in which vaccine experts, infectious disease experts and representatives of companies developing vaccines …
Read More »Drug Regulator Suggests Covid-19 Vaccine Will Be Approved Soon
A vaccine against coronavirus it may be approved in India soon, the country’s top drug regulator hinted on Thursday, saying the country will have a “happy new year with something in hand.” The Comptroller General of Drugs of India (DCGI) assurance comes ahead of a crucial meeting of the expert …
Read More »‘We will probably have a very happy new year’: DCGI on the Covid-19 vaccine
New Delhi: India is likely to have a Covid-19 vaccine in the New Year, India’s general drug controller VG Somani hinted on Thursday. Speaking at a webinar, Somani said most importantly, industry and research organizations have stood the test of time. He said that the vaccine candidates got the funding …
Read More »Covid-19 vaccination test in all states, UT on January 2 | India News
NEW DELHI: On January 2, all state and territory administrations in the union will conduct a Covid-19 vaccination trial to test the links between planning and implementation and identify challenges, the Center said Thursday. The activity is proposed to take place in all state capitals at at least 3 session …
Read More »Ministry of Health launches communication strategy to support the launch of the Covid-19 vaccine | India News
NEW DELHI: The Union Ministry of Health released a communication strategy on Thursday to support the launch of the Covid-19 vaccine in India that seeks to disseminate accurate and transparent information by alleviating apprehensions and ensuring acceptance. The 88-page document details information to guide communication activities at the national, state …
Read More »Why the Oxford vaccine could be India’s best chance against Covid | India News
NEW DELHI: The UK on Wednesday became the first country in the world to approve the coronavirus vaccine developed by the University of Oxford-AstraZeneca. India is likely to follow suit soon. The Serum Institute of India (SII), the world’s largest producer of vaccines, has already produced almost 50 million doses …
Read More »